Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu, A.; Ermis, F.; Akyuz, Filiz; Pinarbasi, B.; Baran, B.; Aydogan, T.; Demir, K.; Besisik, Selman; Kaymakoglu, Sabahattin

Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.18, sa.16, ss.2337-2342, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 16
Basım Tarihi: 2014
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2337-2342
İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: To assess the efficacy and adverse effects of infliximab in patients with Crohn's disease and ulcerative colitis who are resistant to conventional therapy or having fistulising type Crohn's disease.